STERIS’ (TSE:STE) to Post Q3 2024 Earnings of $0.28 Per Share, Atb Cap Markets Forecasts

STERIS’ (TSE:STE) – Analysts at Atb Cap Markets dropped their Q3 2024 earnings estimates for STERIS’ in a report issued on Sunday, April 7th. Atb Cap Markets analyst W. Syed now expects that the company will earn $0.28 per share for the quarter, down from their prior forecast of $0.31. Atb Cap Markets also issued estimates for STERIS’’s Q4 2024 earnings at $0.08 EPS, FY2024 earnings at $0.87 EPS, Q2 2025 earnings at $0.24 EPS, Q3 2025 earnings at $0.33 EPS, Q4 2025 earnings at $0.12 EPS, FY2025 earnings at $1.13 EPS, Q1 2026 earnings at $0.47 EPS and FY2026 earnings at $1.18 EPS.

Separately, Stifel Canada lowered shares of STERIS’ from a “buy” rating to a “hold” rating in a report on Tuesday, March 12th.

STERIS’ Price Performance

STERIS’ (TSE:STE) last released its quarterly earnings results on Monday, March 11th. The company reported C($0.04) earnings per share for the quarter, missing the consensus estimate of C$0.04 by C($0.08). The business had revenue of C$195.05 million for the quarter, compared to analyst estimates of C$208.50 million.

About STERIS’

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.